Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (26)

2024

  1. Gastric metaplasia as a precursor of nonconventional dysplasia in inflammatory bowel disease

    Human Pathology, Vol. 143, pp. 50-61

  2. Lipid fingerprint-based histology accurately classifies nevus, primary melanoma, and metastatic melanoma samples

    International Journal of Cancer, Vol. 154, Núm. 4, pp. 712-722

  3. Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review

    Cancers, Vol. 16, Núm. 1

  4. RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis

    iScience, Vol. 27, Núm. 4

2023

  1. A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients

    Biomedicine and Pharmacotherapy, Vol. 159

  2. Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  3. Extracellular vesicles secreted by triple-negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2153-2165

  4. In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers

    Advanced Science, Vol. 10, Núm. 32

  5. Lymph Node Molecular Analysis with OSNA Enables the Identification of pT1 CRC Patients at Risk of Recurrence: A Multicentre Study

    Cancers, Vol. 15, Núm. 22

  6. Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness

    Molecular Oncology, Vol. 17, Núm. 1, pp. 98-118

  7. Protocol to characterize the melanoma tumor immune microenvironment in mice from single cell to flow cytometry analysis

    STAR Protocols, Vol. 4, Núm. 4

  8. Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402

    Journal of the National Cancer Institute, Vol. 115, Núm. 12, pp. 1497-1505

  9. Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis

    Cancer Communications

2022

  1. ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma

    Molecular Oncology, Vol. 16, Núm. 11, pp. 2235-2259

  2. Abdominal tumors in patients with neurofibromatosis type I: Genotype-phenotype relationships

    European Journal of Medical Genetics, Vol. 65, Núm. 11

  3. Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness

    Frontiers in Cell and Developmental Biology, Vol. 10

  4. M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors

    British Journal of Cancer

  5. Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

    Cancers, Vol. 14, Núm. 12

  6. Myosin Vb as a tumor suppressor gene in intestinal cancer

    Oncogene, Vol. 41, Núm. 49, pp. 5279-5288

2021

  1. Immunologic characterization of COVID-19 patients with hematological cancer

    Haematologica